Published in Blood Weekly, August 29th, 2002
Aprotinin, traditionally extracted from bovine lungs, is currently used therapeutically to reduce the need for blood transfusions in patients undergoing cardiac bypass surgery. ProdiGene holds the patent for exclusive commercial production of aprotinin in all plants.
Aprotinin produced in maize provides an alternative to animal-derived material. ProdiGene's recombinant aprotinin is equivalent to bovine aprotinin but is not limited by the supply of bovine lungs. This is in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.